|
19:00 |
Social hour with the members
of the Society for Non-Invasive Imaging in Drug Development (SNIDD) |
19:30 |
Tim McCarthy, President of
SNIDD |
19:40 |
Business Discussion |
20:00 |
Update on DICOM - The Impact
of HIPAA Regulations
Andrew Kraus, Beacon Bioscience, Doylestown, PA, USA |
20:30 |
The use of Metabonomics
in Drug Safety Evaluations
Dr. Marielle Delnomdedieu, Pfizer |
21:00 |
Experiences in Establishing
Multi-Site MR Trials
Dr. David Saloner, VA Medical Center, Department of Radiology, San
Francisco, CA, USA |
21:30 |
Adjournment |
|